Center for Neurosciences | Tucson, AZ
Status and phase
Conditions
Treatments
Study type
Funder types
Identifiers
About
A study to determine if BHV- 7000 is safe and tolerable in adults with refractory focal onset epilepsy
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Key Inclusion Criteria:
Key Exclusion Criteria:
Primary purpose
Allocation
Interventional model
Masking
660 participants in 2 patient groups
Loading...
Central trial contact
Chief Medical Officer
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal